Skip to main content
Log in

Physicochemical Properties of Solid Dispersions of Gliclazide in Polyvinylpyrrolidone K90

  • Brief/Technical Note
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Reynolds JEF, editor. Martindale. The Extra Pharmacopoiea XXX. 30th edn. London: The Pharmaceutical Press; 1993. p. 279–80.

  2. Palmer KJ, Brogden RN. Gliclazide, an update of its pharmacological properties and therapeutic efficacy in NIDDM. Drugs 1993;46:92–125.

    Article  PubMed  CAS  Google Scholar 

  3. Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system: new scientific approaches to international regulatory standards. Eur J Pharm Biopharm. 2000;50:3–12.

    Article  PubMed  CAS  Google Scholar 

  4. Desai KGH, Kulkarni AR, Aminabhavi TM. Solubility of rofecoxib in presence of methanol, ethanol and sodium lauryl sulfate at (298.15, 303.15 and 308.15) K. J Chem Eng Data. 2003;48:942–5.

    Article  CAS  Google Scholar 

  5. Harrower AD. Comparison of efficacy, secondary failure rate and complications of sulfonylurea. J Diabetes Complicat. 1994;8:201–3.

    Article  PubMed  CAS  Google Scholar 

  6. Özkan Y, Atay T, Díkman N, Isimer A, Aboul-Enein YH. Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with β-cyclodextrin. Pharm Acta Helv. 2000;74:365–70.

    Article  PubMed  Google Scholar 

  7. Winters S, York P, Timmins P. Solid state examination of a gliclazide: beta-cyclodextrin complex. Eur J Pharm Sci. 1997;5:209–14.

    Article  CAS  Google Scholar 

  8. Aggarwal S, Singh PN, Mishra B. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin–hydroxypropylmethylcellulose complexes. Die Pharmazie. 2002;57:191–3.

    PubMed  CAS  Google Scholar 

  9. Hong SS, Lee SH, Lee YJ, Chung SJ, Lee MH, Shim CK. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. J Control Release. 1998;51:185–92.

    Article  PubMed  CAS  Google Scholar 

  10. Biswal S, Sahoo J, Murthy PN, Giradkar PR, Avari JG. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmaSciTech. 2008;9(2):563–70.

    Article  CAS  Google Scholar 

  11. Trapani G, Franco M, Latrofa A, Pantaleo MR, Provenzano MR, Sanna E, et al. Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000. Int J Pharm. 1999;184:121–30.

    Article  PubMed  CAS  Google Scholar 

  12. Trapani G, Franco M, Latrofa A, Tullio C, Provenzano MR, Serra M, et al. Dissolution properties and anticonvulsant activity of phenytoin–polyethylene glycol 6000 and-polyvinylpyrrolidone K-30 solid dispersions. Int J Pharm. 2001;225:63–73.

    Article  PubMed  Google Scholar 

  13. Higuchi T, Connors K. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4:17–123.

    Google Scholar 

  14. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustinjns P, et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci. 2000;10:311–22.

    Article  PubMed  CAS  Google Scholar 

  15. Khan CA, Rhodes CT. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–9.

    PubMed  CAS  Google Scholar 

  16. Arias MJ, Gines JM, Moyano JR, Rabasco AM. Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols. Pharm Acta Helv. 1996;71:229–35.

    Article  PubMed  CAS  Google Scholar 

  17. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–33.

    Article  PubMed  CAS  Google Scholar 

  18. Korsemeyer RW, Gurney R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.

    Article  Google Scholar 

  19. Albertini B, Cavallari C, Passerini N, González-Rodríguez ML, Rodriguez L. Evaluation of b-lactose, PVP K12 and PVP K90 as excipients to prepare piroxicam granules using two wet granulation techniques. Eur J Pharm Biopharm. 2003;56:479–87.

    Article  PubMed  CAS  Google Scholar 

  20. Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm. 1998;164:67–80.

    Article  Google Scholar 

  21. Khougaz K, Clas SD. Crystallization inhibition in solid dispersion of MK-0591 and poly (vinylpyrrolidone) Polymers. J Pharm Sci. 2000;89(10):1325–34.

    Article  PubMed  CAS  Google Scholar 

  22. Karavas E, Ktistis G, Xenakis A, Georgarakis E. Miscibility behavior and formation mechanism of stabilized felodipine–polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm. 2005;31:473–89.

    Article  PubMed  CAS  Google Scholar 

  23. Ford JL. The current status of solid dispersions. Pharm Acta Helv. 1986;61:69–88.

    PubMed  CAS  Google Scholar 

  24. Bettinetti GP, Mura P, Giordano F, Setti M. Thermal behaviour and physico-chemical properties of naproxen in mixtures with polyvinylpyrrolidone. Thermochim Acta. 1991;199:165–71.

    Article  Google Scholar 

  25. Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm. 2003;267:79–91.

    Article  PubMed  CAS  Google Scholar 

  26. Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm. 1999;18:143–51.

    Article  Google Scholar 

  27. Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D, et al. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm. 2004;30(3):303–17.

    Article  PubMed  CAS  Google Scholar 

  28. Nair R, Gonen S, Hoag SW. Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int J Pharm. 2002;240:11–22.

    Article  PubMed  CAS  Google Scholar 

  29. Hosono T, Tsuchiya S, Matsumura H. Model of interaction of ajmaline with polyvinylpyrrolidon. J Pharm Sci. 1980;69:824–6.

    Article  PubMed  CAS  Google Scholar 

  30. Najib NM, Suleiman M, Malakh A. Characteristics of the in vitro release of ibuprofen from polyvinylpyrrolidone solid dispersions. Int J Pharm. 1986;32:229–36.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Aristo Pharmaceuticals Pvt. Ltd, Mumbai, India. Mr. S. Biswal acknowledges the Principal of the Royal College of Pharmacy and Health Sciences, Brahmapur, for providing the necessary facilities.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Biswal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biswal, S., Sahoo, J. & Murthy, P.N. Physicochemical Properties of Solid Dispersions of Gliclazide in Polyvinylpyrrolidone K90. AAPS PharmSciTech 10, 329–334 (2009). https://doi.org/10.1208/s12249-009-9212-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-009-9212-7

Key words

Navigation